1,3-DIMETHYL-5-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)-1H-PYRAZOLE → HCID 23630145, compound
Reaction equation
[NH2:1][C:2]1[C:11]2[C:6](=[C:7](Br)[CH:8]=[CH:9][CH:10]=2)[N:5]=[N:4][C:3]=1[C:13]([NH:15][CH2:16][CH2:17][CH3:18])=[O:14].[CH3:19][N:20]1[C:24](B2OC(C)(C)C(C)(C)O2)=[CH:23][C:22]([CH3:34])=[N:21]1>>[NH2:1][C:2]1[C:11]2[C:6](=[C:7]([C:24]3[N:20]([CH3:19])[N:21]=[C:22]([CH3:34])[CH:23]=3)[CH:8]=[CH:9][CH:10]=2)[N:5]=[N:4][C:3]=1[C:13]([NH:15][CH2:16][CH2:17][CH3:18])=[O:14]Participants
3
Procedure
Using method A, 4-amino-8-bromo-N-propyl-cinnoline-3-carboxamide (200 mg, 0.647 mmol) and 1,3-dimethyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole (288 mg, 1.297 mmol) were reacted to afford the title compound (45 mg, 21% yield) as a white solid.
Workup
- customwere reacted
Sources & evidence
- ORD record
- ord-0a79f1c1539842b7a15ab045d002222c
- Source dataset
- uspto-grants-2008_12
- Patent number
- US07465795B2
Reaction notes
Loading…